Complement factor H related proteins (CFHRs)

Molecular Immunology

Volumn 56, Issue 3, 2013, Pages 170-180

  Skerka, Christine ^a   Chen, Qian ^a   Fremeaux Bacchi, Veronique ^b,c   Roumenina, Lubka T ^b,d,e  

^a HANS KNÖLL INSTITUTE   (Germany)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; CLUSTERIN; COMPLEMENT; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED 1 PROTEIN; COMPLEMENT FACTOR H RELATED 2 PROTEIN; COMPLEMENT FACTOR H RELATED 3 PROTEIN; COMPLEMENT FACTOR H RELATED 4 PROTEIN; COMPLEMENT FACTOR H RELATED 5 PROTEIN; COMPLEMENT FACTOR H RELATED PROTEIN; LECTIN; PLASMA PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VITRONECTIN;

BACTERIAL STRAIN; CANDIDA ALBICANS; CHROMOSOME 1; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DISORDER; COMPLEMENT SYSTEM; CROSS REACTION; DIMERIZATION; GENE CLUSTER; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN A NEPHROPATHY; LYMPHOCYTE DIFFERENTIATION; MOLECULAR RECOGNITION; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

APOLIPOPROTEINS; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MACULAR DEGENERATION; MULTIGENE FAMILY;

EID: 84880767415     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.06.001     Document Type: Review

References (115)

1. Abarrategui-Garrido C., Martinez-Barricarte R., Lopez-Trascasa M., de Cordoba S.R., Sanchez-Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 2009, 114:4261-4271.
2. Abrera-Abeleda M.A., Nishimura C., Smith J.L., Sethi S., McRae J.L., Murphy B.F., Silvestri G., Skerka C., Jozsi M., Zipfel P.F., Hageman G.S., Smith R.J. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 2006, 43:582-589.
3. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
4. Athanasiou Y., Voskarides K., Gale D.P., Damianou L., Patsias C., Zavros M., Maxwell P.H., Cook H.T., Demosthenous P., Hadjisavvas A., Kyriacou K., Zouvani I., Pierides A., Deltas C. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin. J. Am. Soc. Nephrol. 2011, 6:1436-1446.
5. Behnsen J., Hartmann A., Schmaler J., Gehrke A., Brakhage A.A., Zipfel P.F. The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect. Immun. 2008, 76:820-827.
6. Bhakdi S., Tranum-Jensen J. Damage to cell membranes by pore-forming bacterial cytolysins. Prog. Allergy 1988, 40:1-43.
7. Bienaime F., Dragon-Durey M.A., Regnier C.H., Nilsson S.C., Kwan W.H., Blouin J., Jablonski M., Renault N., Rameix-Welti M.A., Loirat C., Sautes-Fridman C., Villoutreix B.O., Blom A.M., Fremeaux-Bacchi V. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 2010, 77:339-349.
8. Blackmore T.K., Fischetti V.A., Sadlon T.A., Ward H.M., Gordon D.L. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect. Immun. 1998, 66:1427-1431.
9. Blanc C., Roumenina L.T., Ashraf Y., Hyvärinen S., Sethi S.K., Ranchin B., Niaudet P., Loirat C., Gulati A., Bagga A., Fridman W.H., Sautès-Fridman C., Jokiranta T.S., Frémeaux-Bacchi V., Dragon-Durey M.A. Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome. J. Immunol. 2012, 189:3528-3537.
10. Castiblanco-Valencia M.M., Fraga T.R., Silva L.B., Monaris D., Abreu P.A., Strobel S., Jozsi M., Isaac L., Barbosa A.S. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J. Infect. Dis. 2012, 205:995-1004.
11. Chen Q., Muller D., Rudolph B., Hartmann A., Kuwertz-Broking E., Wu K., Kirschfink M., Skerka C., Zipfel P.F. Combined C3b and factor B autoantibodies and MPGN type II. N. Engl. J. Med. 2011, 365:2340-2342.
12. Chen Q., Wiesener M., Eberhardt H., Hartmann A., Hugo C., Skerka C., Zipfel P.F. A novel hybrid CFHR2/CFHR5 gene develops MPGN II and provides insights into disease mechanism and therapeutic implications. Immunobiology 2012, 217:1131-1132.
13. Davila S., Wright V.J., Khor C.C., Sim K.S., Binder A., Breunis W.B., Inwald D., Nadel S., Betts H., Carrol E.D., de Groot R., Hermans P.W., Hazelzet J., Emonts M., Lim C.C., Kuijpers T.W., Martinon-Torres F., Salas A., Zenz W., Levin M., Hibberd M.L. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 2010, 42:772-776. International Meningococcal Genetics Consortium.
14. Deltas C., Gale D., Cook T., Voskarides K., Athanasiou Y., Pierides A. C3 Glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families. Adv. Exp. Med. Biol. 2013, 734:189-196.
15. Delvaeye M., Noris M., De Vriese A., Esmon C.T., Esmon N.L., Ferrell G., Del-Favero J., Plaisance S., Claes B., Lambrechts D., Zoja C., Remuzzi G., Conway E.M. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009, 361(July (4)):345-357. 10.1056/NEJMoa0810739.
16. Diaz-Guillen M.A., Rodriguez de Cordoba S., Heine-Suner D. A radiation hybrid map of complement factor H and factor H-related genes. Immunogenetics 1999, 49:549-552.
17. Dragon-Durey M.A., Loirat C., Cloarec S., Macher M.A., Blouin J., Nivet H., Weiss L., Fridman W.H., Frémeaux-Bacchi V. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2005, 16:555-563.
18. Dragon-Durey M.A., Blanc C., Marliot F., Loirat C., Blouin J., Sautes-Fridman C., Fridman W.H., Fremeaux-Bacchi V. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J. Med. Genet. 2009, 46:447-450.
19. Eberhardt H.U., Uzonyi B., Hälbich S., Zipfel P.F., Skerka C. Complement factor H-related protein 2 (CFHR2) is a C3b and heparin binding protein. Medimont International Proceedings, 2nd European Congress of Immunology 2009, R.E. Schmidt (Ed.).
20. Eberhardt H.E., Chen Q., Zipfel P., Skerka C. Human complement factor H-related protein 2 (CFHR2) represents a novel complement regulator, which is reduced in a patient with MPGN. Mol. Immunol. 2011, 48:1674.
21. Eberhardt H.U., Skerka C., Zipfel P.F., Hallström T., Hartmann A., Chen Q. C3-glomerulopathy associated human factor H-related proteins 2 (CFHR2) and 5 (CFHR5) regulate complement C3b and TCC. Immunobiology 2012, 217:1143.
22. Fakhouri F., Frémeaux-Bacchi V., Noël L.H., Cook H.T., Pickering M.C. C3 glomerulopathy: a new classification. Nat. Rev. Nephrol. 2010, 6:494-499.
23. Francis N.J., McNicholas B., Awan A., Waldron M., Reddan D., Sadlier D., Kavanagh D., Strain L., Marchbank K.J., Harris C.L., Goodship T.H. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 2012, 119:591-601.
24. Fremeaux-Bacchi V., Fakhouri F., Garnier A., Bienaime F., Dragon-Durey M.A., Ngo S., Moulin B., Servais A., Provot F., Rostaing L., Burtey S., Niaudet P., Deschenes G., Lebranchu Y., Zuber J., Loirat C. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin. J. Am. Soc. Nephrol. 2013, 8:554-562.
25. Fritsche L.G., Lauer N., Hartmann A., Stippa S., Keilhauer C.N., Oppermann M., Pandey M.K., Kohl J., Zipfel P.F., Weber B.H., Skerka C. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 2010, 19:4694-4704.
26. Fritsche L.G., Chen W., Schu M., Yaspan B.L., Yu Y., Thorleifsson G., Zack D.J., Arakawa S., Cipriani V., Ripke S., Igo R.P., Buitendijk G.H., Sim X., Weeks D.E., Guymer R.H., Merriam J.E., Francis P.J., Hannum G., Agarwal A., Armbrecht A.M., Audo I., Aung T., Barile G.R., Benchaboune M., Bird A.C., Bishop P.N., Branham K.E., Brooks M., Brucker A.J., Cade W.H., Cain M.S., Campochiaro P.A., Chan C.C., Cheng C.Y., Chew E.Y., Chin K.A., Chowers I., Clayton D.G., Cojocaru R., Conley Y.P., Cornes B.K., Daly M.J., Dhillon B., Edwards A.O., Evangelou E., Fagerness J., Ferreyra H.A., Friedman J.S., Geirsdottir A., George R.J., Gieger C., Gupta N., Hagstrom S.A., Harding S.P., Haritoglou C., Heckenlively J.R., Holz F.G., Hughes G., Ioannidis J.P., Ishibashi T., Joseph P., Jun G., Kamatani Y., Katsanis N., Khan C.N.K., Kim J.C., Kiyohara I.K., Klein Y., Klein B.E., Kovach R., Kozak J.L., Lee I., Lee C.J., Lichtner K.E., Lotery P., Meitinger A.J., Mitchell T., Mohand-Said P., Moore S., Morgan A.T., Morrison D.J., Myers M.A., Naj C.E., Nakamura A.C., Okada Y., Orlin Y., Ortube A., Othman M.C., Pappas M.I., Park C., Pauer K.H., Peachey G.J., Poch N.S., Priya O., Reynolds R.R., Richardson R., Ripp A.J., Rudolph R., Ryu G. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439.
27. Gale D.P., de Jorge E.G., Cook H.T., Martinez-Barricarte R., Hadjisavvas A., McLean A.G., Pusey C.D., Pierides A., Kyriacou K., Athanasiou Y., Voskarides K., Deltas C., Palmer A., Fremeaux-Bacchi V., de Cordoba S.R., Maxwell P.H., Pickering M.C. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010, 376:794-801.
28. Gharavi A.G., Kiryluk K., Choi M., Li Y., Hou P., Xie J., Sanna-Cherchi S., Men C.J., Julian B.A., Wyatt R.J., Novak J., He J.C., Wang H., Lv J., Zhu L., Wang W., Wang Z., Yasuno K., Gunel M., Mane S., Umlauf S., Tikhonova I., Beerman I., Savoldi S., Magistroni R., Ghiggeri G.M., Bodria M., Lugani F., Ravani P., Ponticelli C., Allegri L., Boscutti G., Frasca G., Amore A., Peruzzi L., Coppo R., Izzi C., Viola B.F., Prati E., Salvadori M., Mignani R., Gesualdo L., Bertinetto F., Mesiano P., Amoroso A., Scolari F., Chen N., Zhang H., Lifton R.P. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 2011, 43:321-327.
29. Goicoechea de Jorge E.G., Caeser J., Malik T.H., Patel M.M., Colledge M., Johnson S., Harris C.L., Pickering M.C., Lea S.M. Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy. Immunobiology 2012, 217:1205.
30. Goicoechea de Jorge E., Caesar J.J., Malik T.H., Patel M., Colledge M., Johnson S., Hakobyan S., Morgan B.P., Harris C.L., Pickering M.C., Lea S.M. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:4685-4690.
31. Haapasalo K., Meri T., Jokiranta T.S. Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma. Infect. Immun. 2009, 77:3886-3893.
32. Hallström T., Morgelin M., Barthel D., Raguse M., Kunert A., Hoffmann R., Skerka C., Zipfel P.F. Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen. J. Immunol. 2012, 189:4939-4950.
33. Haupt K., Kraiczy P., Wallich R., Brade V., Skerka C., Zipfel P.F. Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins. J. Infect. Dis. 2007, 196:124-133.
34. Hebecker M., Okemefuna A.I., Perkins S.J., Mihlan M., Huber-Lang M., Jozsi M. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4. Mol. Immunol. 2010, 47:1347-1355.
35. Heinen S., Sanchez-Corral P., Jackson M.S., Strain L., Goodship J.A., Kemp E.J., Skerka C., Jokiranta T.S., Meyers K., Wagner E., Robitaille P., Esparza-Gordillo J., Rodriguez de Cordoba S., Zipfel P.F., Goodship T.H. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum. Mutat. 2006, 27:292-293.
36. Heinen S., Hartmann A., Lauer N., Wiehl U., Dahse H.M., Schirmer S., Gropp K., Enghardt T., Wallich R., Halbich S., Mihlan M., Schlotzer-Schrehardt U., Zipfel P.F., Skerka C. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 2009, 114:2439-2447.
37. Hellwage J., Jokiranta T.S., Koistinen V., Vaarala O., Meri S., Zipfel P.F. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett. 1999, 462:345-352.
38. Hellwage J., Meri T., Heikkila T., Alitalo A., Panelius J., Lahdenne P., Seppala I.J., Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 2001, 276:8427-8435.
39. Herbert A.P., Deakin J.A., Schmidt C.Q., Blaum B.S., Egan C., Ferreira V.P., Pangburn M.K., Lyon M., Uhrin D., Barlow P.N. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J. Biol. Chem. 2007, 282:18960-18968.
40. Herbert A.P., Kavanagh D., Johansson C., Morgan H.P., Blaum B.S., Hannan J.P., Barlow P.N., Uhrin D. Structural and functional characterization of the product of disease-related factor H gene conversion. Biochemistry 2012, 51:1874-1884.
41. Holmes L.V., Strain L., Staniforth S.J., Moore I., Marchbank K., Kavanagh D., Goodship J.A., Cordell H.J., Goodship T.H. Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32. PLoS One 2013, 8:e60352.
42. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12:682-687.
43. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
44. Jozsi M., Richter H., Loschmann I., Skerka C., Buck F., Beisiegel U., Erdei A., Zipfel P.F. FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur. J. Hum. Genet. 2005, 13:321-329.
45. Jozsi M., Strobel S., Dahse H.M., Liu W.S., Hoyer P.F., Oppermann M., Skerka C., Zipfel P.F. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 2007, 110:1516-1518.
46. Jozsi M., Licht C., Strobel S., Zipfel S.L., Richter H., Heinen S., Zipfel P.F., Skerka C. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008, 111:1512-1514.
47. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
48. Kopp A., Strobel S., Tortajada A., Rodríguez de Córdoba S., Sánchez-Corral P., Prohászka Z., López-Trascasa M., Józsi M. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3. J. Immunol. 2012, 15(189):1858-1867.
49. Kotarsky H., Hellwage J., Johnsson E., Skerka C., Svensson H.G., Lindahl G., Sjobring U., Zipfel P.F. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J. Immunol. 1998, 160:3349-3354.
50. Kraiczy P., Hartmann K., Hellwage J., Skerka C., Kirschfink M., Brade V., Zipfel P.F., Wallich R., Stevenson B. Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int. J. Med. Microbiol. 2004, 37(293 Suppl.):152-157.
51. Kraiczy P., Hellwage J., Skerka C., Becker H., Kirschfink M., Simon M.M., Brade V., Zipfel P.F., Wallich R. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J. Biol. Chem. 2004, 279:2421-2429.
52. Krid S., Roumenina L.T., Beury D., Charbit M., Boyer O., Fremeaux-Bacchi V., Niaudet P. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein. Am. J. Transplant 2012, 12:1938-1944.
53. Kunert A., Losse J., Gruszin C., Huhn M., Kaendler K., Mikkat S., Volke D., Hoffmann R., Jokiranta T.S., Seeberger H., Moellmann U., Hellwage J., Zipfel P.F. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 2007, 179:2979-2988.
54. Leban N., Abarrategui-Garrido C., Fariza-Requejo E., Aminoso-Carbonero C., Pinto S., Chibani J.B., Khelil A.H., Sanchez-Corral P. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations. Int. J. Immunogenet. 2012, 39:110-113.
55. Lehtinen M.J., Rops A.L., Isenman D.E., van der Vlag J., Jokiranta T.S. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J. Biol. Chem. 2009, 284:15650-15658.
56. Lemaire M., Frémeaux-Bacchi V., Schaefer F., Choi M., Tang W.H., Le Quintrec M., Fakhouri F., Taque S., Nobili F., Martinez F., Ji W., Overton J.D., Mane S.M., Nürnberg G., Altmüller J., Thiele H., Morin D., Deschenes G., Baudouin V., Llanas B., Collard L., Majid M.A., Simkova E., Nürnberg P., Rioux-Leclerc N., Moeckel G.W., Gubler M.C., Hwa J., Loirat C., Lifton R.P. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat. Genet. 2013, 45(April (5)):531-536. Epub 2013 March 31. 10.1038/ng.2590.
57. Licht C., Heinen S., Jozsi M., Loschmann I., Saunders R.E., Perkins S.J., Waldherr R., Skerka C., Kirschfink M., Hoppe B., Zipfel P.F. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int. 2006, 70:42-50.
58. Losse J., Zipfel P.F., Jozsi M. Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J. Immunol. 2010, 184:912-921.
59. Luo S., Hartmann A., Dahse H.M., Skerka C., Zipfel P.F. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3. J. Immunol. 2010, 185:2164-2173.
60. Luo S., Blom A.M., Rupp S., Hipler U.C., Hube B., Skerka C., Zipfel P.F. The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J. Biol. Chem. 2011, 286:8021-8029.
61. Maga T.K., Nishimura C.J., Weaver A.E., Frees K.L., Smith R.J. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum. Mutat. 2010, 31:E1445-E1460.
62. Maga T.K., Meyer N.C., Belsha C., Nishimura C.J., Zhang Y., Smith R.J. A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome. Nephrol. Dial. Transplant 2011, 26:739-741.
63. Male D.A., Ormsby R.J., Ranganathan S., Giannakis E., Gordon D.L. Complement factor H: sequence analysis of 221kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Mol. Immunol. 2000, 37:41-52.
64. Malik T.H., Lavin P.J., Goicoechea de Jorge E., Vernon K.A., Rose K.L., Patel M.P., de Leeuw M., Neary J.J., Conlon P.J., Winn M.P., Pickering M.C. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J. Am. Soc. Nephrol. 2012, 23:1155-1160.
65. Manuelian T., Hellwage J., Meri S., Caprioli J., Noris M., Heinen S., Jozsi M., Neumann H.P., Remuzzi G., Zipfel P.F. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Invest. 2003, 111:1181-1190.
66. Martinez-Barricarte R., Heurich M., Valdes-Canedo F., Vazquez-Martul E., Torreira E., Montes T., Tortajada A., Pinto S., Lopez-Trascasa M., Morgan B.P., Llorca O., Harris C.L., Rodriguez de Cordoba S. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J. Clin. Invest. 2010, 120:3702-3712.
67. Martinez-Barricarte R., Recalde S., Fernandez-Robredo P., Millan I., Olavarrieta L., Vinuela A., Perez-Perez J., Garcia-Layana A., Rodriguez de Cordoba S. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2012, 53:1087-1094.
68. McRae J.L., Duthy T.G., Griggs K.M., Ormsby R.J., Cowan P.J., Cromer B.A., McKinstry W.J., Parker M.W., Murphy B.F., Gordon D.L. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 2005, 174:6250-6256.
69. Meri T., Hartmann A., Lenk D., Eck R., Würzner R., Hellwage J., Meri S., Zipfel P.F. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 2002, 70:5185-5192.
70. Meri T., Murgia R., Stefanel P., Meri S., Cinco M. Regulation of complement activation at the C3-level by serum resistant leptospires. Microb. Pathog. 2005, 39:139-147.
71. Mihlan M., Hebecker M., Dahse H.M., Halbich S., Huber-Lang M., Dahse R., Zipfel P.F., Jozsi M. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. Mol. Immunol. 2009, 46:335-344.
72. Miller J.W. Age-related macular degeneration revisited - piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am. J. Ophthalmol. 2013, 155:1-35. e13.
73. Moore I., Strain L., Pappworth I., Kavanagh D., Barlow P.N., Herbert A.P., Schmidt C.Q., Staniforth S.J., Holmes L.V., Ward R., Morgan L., Goodship T.H., Marchbank K.J. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010, 115:379-387.
74. Morgan B.P. Regulation of the complement membrane attack pathway. Crit. Rev. Immunol. 1999, 19:173-198.
75. Morgan H.P., Mertens H.D., Guariento M., Schmidt C.Q., Soares D.C., Svergun D.I., Herbert A.P., Barlow P.N., Hannan J.P. Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH). PLoS One 2012, 7:e32187.
76. Muller-Eberhard H.J. The membrane attack complex of complement. Annu. Rev. Immunol. 1986, 4:503-528.
77. Murphy B., Georgiou T., Machet D., Hill P., McRae J. Factor H-related protein-5: a novel component of human glomerular immune deposits. Am. J. Kidney Dis. 2002, 39:24-27.
78. Nester C., Stewart Z., Myers D., Jetton J., Nair R., Reed A., Thomas C., Smith R., Brophy P. Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 2011, 6:1488-1494.
79. Ngampasutadol J., Ram S., Gulati S., Agarwal S., Li C., Visintin A., Monks B., Madico G., Rice P.A. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J. Immunol. 2008, 180:3426-3435.
80. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009, 361:1676-1687.
81. Oliver M.A., Garcia-Delafuente C., Cano M.E., Perez-Hernandez F., Martinez-Martinez L., Alberti S. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain). J. Antimicrob. Chemother. 2007, 60:450-452.
82. Pandiripally V., Wei L., Skerka C., Zipfel P.F., Cue D. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect. Immun. 2003, 71:7119-7128.
83. Park C.T., Wright S.D. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J. Biol. Chem. 1996, 271:18054-18060.
84. Perez-Caballero D., Garcia-Laorden I., Cortes G., Wessels M.R., de Cordoba S.R., Alberti S. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules. J. Immunol. 2004, 173:6899-6904.
85. Ram S., Mackinnon F.G., Gulati S., McQuillen D.P., Vogel U., Frosch M., Elkins C., Guttormsen H.K., Wetzler L.M., Oppermann M., Pangburn M.K., Rice P.A. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 1999, 36:915-928.
86. Raychaudhuri S., Iartchouk O., Chin K., Tan P.L., Tai A.K., Ripke S., Gowrisankar S., Vemuri S., Montgomery K., Yu Y., Reynolds R., Zack D.J., Campochiaro B., Campochiaro P., Katsanis N., Daly M.J., Seddon J.M. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 2011, 43(12):1232-1236. 10.1038/ng.976.
87. Reuter M., Caswell C.C., Lukomski S., Zipfel P.F. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J. Biol. Chem. 2010, 285:38473-38485.
88. Ricklin D., Hajishengallis G., Yang K., Lambris JD Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
89. Rodriguez de Cordoba S., Tortajada A., Harris C.L., Morgan B.P. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology 2012, 217:1034-1046.
90. Roumenina L.T., Loirat C., Dragon-Durey M.A., Halbwachs-Mecarelli L., Sautes-Fridman C., Fremeaux-Bacchi V. Alternative complement pathway assessment in patients with atypical HUS. J. Immunol. Methods 2011, 365:8-26.
91. Servais A., Noel L.H., Roumenina L.T., Le Quintrec M., Ngo S., Dragon-Durey M.A., Macher M.A., Zuber J., Karras A., Provot F., Moulin B., Grunfeld J.P., Niaudet P., Lesavre P., Fremeaux-Bacchi V. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 2012, 82:454-464.
92. Sethi S., Fervenza F.C. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin. Nephrol. 2011, 31:341-348.
93. Skerka C., Horstmann R.D., Zipfel P.F. Molecular cloning of a human serum protein structurally related to complement factor H. J. Biol. Chem. 1991, 266:12015-12020.
94. Skerka C., Timmann C., Horstmann R.D., Zipfel P.F. Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. J. Immunol. 1992, 148:3313-3318.
95. Skerka C., Kuhn S., Gunther K., Lingelbach K., Zipfel P.F. A novel short consensus repeat-containing molecule is related to human complement factor H. J. Biol. Chem. 1993, 268:2904-2908.
96. Skerka C., Hellwage J., Weber W., Tilkorn A., Buck F., Marti T., Kampen E., Beisiegel U., Zipfel P.F. The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J. Biol. Chem. 1997, 272:5627-5634.
97. Skerka C., Józsi M., Zipfel P.F., Dragon-Durey M.A., Fremeaux-Bacchi V. Autoantibodies in hemolytic uremic syndrome (HUS). Thromb. Haemost. 2008, 100:1-6.
98. Stevenson B. Borrelia burgdorferi erp (ospE-related) gene sequences remain stable during mammalian infection. Infect. Immun. 2002, 70:5307-5311.
99. Susukida R., Kido A., Oya M., Mabuchi T. Genetic analysis of human complement factor H polymorphisms. Electrophoresis 2007, 28:309-316.
100. Timmann C., Leippe M., Horstmann R.D. Two major serum components antigenically related to complement factor H are different glycosylation forms of a single protein with no factor H-like complement regulatory functions. J. Immunol. 1991, 146:1265-1270.
101. Tortajada A., Yébenes H., Abarrategui-Garrido C., Anter J., García-Fernández J.M., Martínez-Barricarte R., Alba-Domínguez M., Malik T.H., Bedoya R., Pérez R.C., Trascasa M.L., Pickering M.C., Harris C.L., Sánchez-Corral P., Llorca O., Rodríguez de Córdoba S. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. J Clin Invest. 2013, in press.
102. Venables J.P., Strain L., Routledge D., Bourn D., Powell H.M., Warwicker P., Diaz-Torres M.L., Sampson A., Mead P., Webb M., Pirson Y., Jackson M.S., Hughes A., Wood K.M., Goodship J.A., Goodship T.H. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 2006, 3:e431.
103. Verma A., Hellwage J., Artiushin S., Zipfel P.F., Kraiczy P., Timoney J.F., Stevenson B. LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect. Immun. 2006, 74:2659-2666.
104. Vernon K.A., Goicoechea de Jorge E., Hall A.E., Fremeaux-Bacchi V., Aitman T.J., Cook H.T., Hangartner R., Koziell A., Pickering M.C. Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am. J. Kidney Dis. 2012, 60:121-125.
105. Vogl G., Lesiak I., Jensen D.B., Perkhofer S., Eck R., Speth C., Lass-Florl C., Zipfel P.F., Blom A.M., Dierich M.P., Wurzner R. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol. Immunol. 2008, 45:1485-1493.
106. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
107. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
108. Wang L., Clark M.E., Crossman D.K., Kojima K., Messinger J.D., Mobley J.A., Curcio C.A. Abundant lipid and protein components of drusen. PLoS One 2010, 5:e10329.
109. Ward P.A. Functions of C5a receptors. J. Mol. Med. (Berl.) 2009, 87:375-378.
110. Weismann D., Hartvigsen K., Lauer N., Bennett K.L., Scholl H.P., Charbel Issa P., Cano M., Brandstatter H., Tsimikas S., Skerka C., Superti-Furga G., Handa J.T., Zipfel P.F., Witztum J.L., Binder C.J. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81.
111. Westra D., Vernon K.A., Volokhina E.B., Pickering M.C., van de Kar N.C., van den Heuvel L.P. Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene. J. Hum. Genet. 2012, 57:459-464.
112. Zhao J., Wu H., Khosravi M., Cui H., Qian X., Kelly J.A., Kaufman K.M., Langefeld C.D., Williams A.H., Comeau M.E., Ziegler J.T., Marion M.C., Adler A., Glenn S.B., Alarcon-Riquelme M.E., Pons-Estel B.A., Harley J.B., Bae S.C., Bang S.Y., Cho S.K., Jacob C.O., Vyse T.J., Niewold T.B., Gaffney P.M., Moser K.L., Kimberly R.P., Edberg J.C., Brown E.E., Alarcon G.S., Petri M.A., Ramsey-Goldman R., Vila L.M., Reveille J.D., James J.A., Gilkeson G.S., Kamen D.L., Freedman B.I., Anaya J.M., Merrill J.T., Criswell L.A., Scofield R.H., Stevens A.M., Guthridge J.M., Chang D.M., Song Y.W., Park J.A., Lee E.Y., Boackle S.A., Grossman J.M., Hahn B.H., Goodship T.H., Cantor R.M., Yu C.Y., Shen N., Tsao B.P. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011, 7:e1002079.
113. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.
114. Zipfel P.F., Edey M., Heinen S., Jozsi M., Richter H., Misselwitz J., Hoppe B., Routledge D., Strain L., Hughes A.E., Goodship J.A., Licht C., Goodship T.H., Skerka C. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007, 3:e41.
115. Zipfel P.F., Mache C., Muller D., Licht C., Wigger M., Skerka C. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr. Nephrol. 2010, 25:2009-2019.